Biologics in Systemic Sclerosis

E-ISSN： 1873-4316|15|6|549-557

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.15, Iss.6, 2014-06, pp. : 549-557

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biologics in Inflammatory Immune-mediated Systemic Diseases

Current Pharmaceutical Biotechnology, Vol. 18, Iss. 12, 2018-03 ,pp. : 1008-1016

Bentham Science Publishers

Access to resources Recommend Favorite

Management of systemic sclerosis

By Ong Voon H Brough Geraldine Denton Christopher P

Clinical Medicine, Vol. 5, Iss. 3, 2005-05 ,pp. : 214-219

Royal College Of Physicians

Access to resources Recommend Favorite

Targeting Fibrosis in Systemic Sclerosis

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 4, 2006-12 ,pp. : 395-400

Bentham Science Publishers

Access to resources Recommend Favorite

Animal Models of Systemic Sclerosis

Current Pharmaceutical Design, Vol. 21, Iss. 18, 2015-06 ,pp. : 2365-2379

Bentham Science Publishers

Access to resources Recommend Favorite

Biologics as Treatment for Systemic Lupus: Great Efforts, Sobering Results, New Challenges

Current Drug Discovery Technologies, Vol. 6, Iss. 4, 2009-12 ,pp. : 252-255

Bentham Science Publishers

Access to resources Recommend Favorite